News

NEWS

SEPTEMBER 8th, 2020

READ MORE

TFS Announces Partnership with the DCRI

MAY 27th, 2020

READ MORE

Demonstrating strong customer focus and therapeutic expertise, TFS CRO has been awarded new Covid-19 studies.

MAY 19th, 2020

READ MORE

TFS partners with Veeva to offer new, innovative safety database solution for its trials

MAY 12th, 2020

READ MORE

TFS obtient l'agrement CIR en tant qu'une societe de recherche contractuelle (CRO) prive.

APRIL 1st, 2020

READ MORE

TFS forms partnership to conduct a global RWE study on Covid-19 pandemic.

MARCH 16th, 2020

READ MORE

TFS's approach to recent developments regarding the Coronavirus (COVID-19).

MARCH 9th, 2020

READ MORE

TFS presents TrialOnline - digital solution for patient retention and data collection as an example of a successful industry partnership

FEBRUARY 5th, 2020

READ MORE

Secrets to Biotech Success, a TFS seminar series, goes to Germany

DECEMBER 19th, 2019

READ MORE

TFS joins Medidata Partner Program with Rave EDC accreditation.

DECEMBER 17th, 2019

READ MORE

Bassem Saleh appointed new CEO of TFS

DECEMBER 13th, 2019

READ MORE

TFS CEO featured in Pharma Boardroom

SEPTEMBER 24th, 2019

READ MORE

TFS seminar Secrets to Biotech Success

MARCH 4th, 2019

READ MORE

TFS International AB (TFS) appointed CRO representative for TIKOMED's phase 2 study in clinical islet transplantation

JANUARY 14th, 2019

READ MORE

Ratos acquires remaining shares in TFS

DECEMBER 7th, 2018

READ MORE

A wider framework is needed to manage clinical trials more effectively. Article in EPC Nov. 2018 by Dr. Suzanne Pavon, Exec. VP Quality & Compliance

OCTOBER 8th, 2018

READ MORE

TFS collaboration with Lobsor Pharmaceuticals AB, on the development of Lecigon®, has resulted in marketing authorization of Lecigon® in Sweden.

JUNE 20th, 2018

READ MORE

TFS International appoints Dr Suzanne Pavon as Executive Vice President, Quality Assurance

JUNE 8th, 2018

READ MORE

WEBINAR: TFS & Technology - Our Approach To Study Start-Up

APRIL 4th, 2018

READ MORE

TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal

APRIL 3rd, 2018

READ MORE

TFS International appoints Dr Andrew Copestake as Chief Commercial Officer

JANUARY 25th, 2018

READ MORE

Araclon Biotech partners with TFS International for their Alzheimer's Phase II Trial

JANUARY 10th, 2018

READ MORE

TFS International Appoints New Chief Executive Officer

NOVEMBER 28th, 2017

READ MORE

TFS Global Newsletter November

NOVEMBER 27th, 2017

READ MORE

TFS shortlisted among the 20 Most Promising Pharma and Life Science Tech Solution Providers 2017

OCTOBER 17th, 2017

READ MORE

TFS Global Newsletter October

JULY 13th, 2017

READ MORE

TFS International Appoints Mr. Ryan Shortreed as CFO, Mr. Martin Filippides as Vice President HR and Mr Young Shon as CIO

APRIL 21st, 2017

READ MORE

Diamyd has contracted TFS for a clinical trial in children and young adults recently diagnosed with type 1 diabetes

APRIL 19th, 2017

READ MORE

TFS Dermatology Team awarded the Top Job Seal

MARCH 22nd, 2017

READ MORE

TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward (Ed) Tumaian as VP Global Clinical Development

OCTOBER 27th, 2016

READ MORE

TFS awarded Excellence in Innovation at OmniComm Innovation Forum 2016

OCTOBER 11th, 2016

READ MORE

TFS acquires dermatology specialist SCIderm

JUNE 27th, 2016

READ MORE

TFS Announces Appointment of Dr. Birgitte Volck as non-executive Board Member

APRIL 19th, 2016

READ MORE

TiGenix selects TFS for the first clinical trial to treat severe sepsis with allogeneic expanded adipose-derived stem cells.

MARCH 14th, 2016

READ MORE

Implanet decides on TFS as strategic development partner in a US multicenter study

MARCH 1st, 2016

READ MORE

TFS appoints Dr. Montserrat Barceló Riera as Chief Operating Officer

NOVEMBER 2nd, 2015

READ MORE

LobSor Pharmaceuticals and TFS report LECIGon® Achieving Its Primary Endpoint in a Pivotal EU Study for Advanced Parkinson's Disease

JUNE 11th, 2015

READ MORE

TFS and LobSor Pharmaceuticals advance their risk-sharing partnership in Parkinson's disease to the clinics

APRIL 16th, 2015

READ MORE

TFS relocates North American headquarters to Princeton

OCTOBER 28th, 2014

READ MORE

TFS and SCIderm enter into a Strategic Partnership in Dermatology

SEPTEMBER 9th, 2014

READ MORE

TFS Appoints new VP, Global Clinical Development

MAY 19th, 2014

READ MORE

Merck Serono selects TFS as a Preferred Provider for Phase IV Studies in Western Europe and North America

APRIL 30th, 2014

READ MORE

TFS launches new Website

FEBRUARY 25th, 2014

READ MORE

TFS Appoints new VP North American Operations

FEBRUARY 4th, 2014

READ MORE

TFS appoints two Executive VP positions

NOVEMBER 26th, 2013

READ MORE

A call to advocacy

MAY 31st, 2013

READ MORE

An interview with Daniel Spasic, CEO of TFS (in Swedish) January 2012

FEBRUARY 28th, 2012

READ MORE

Alemany Amparo at TFS named in published article: "The Paediatric Working Group of EUCROF"

JANUARY 31st, 2012

READ MORE

TFS wants to turn talk into action